• About
  • Advertise
  • Write For Us
  • Privacy Policy
  • Contact Us
Subscribe
Smart Investor Malaysia
Advertisement
  • Start Here
    • Guides
    • How-Tos
    • Analysis
  • Investments
    • Asset Management
    • Stocks
    • Islamic Finance
      • Islamic Personal Finance
    • Alternative Investments
  • Personal Finance
    • Cash Management
    • Grow Your Wealth
    • Protect Your Wealth
    • Distribute Your Wealth
    • Behavioural Finance
  • Enterprise
    • Startups
    • Entrepreneurs
    • SMEs
    • Leadership
    • Business Planning
    • Fintech
  • Property
    • First Time Home Buyers
    • Central
    • Northern
    • Southern
    • Sabah & Sarawak
    • Feature
    • Regional / Global
  • ESG
  • News & Events
  • What’s News Asia
No Result
View All Result
  • Start Here
    • Guides
    • How-Tos
    • Analysis
  • Investments
    • Asset Management
    • Stocks
    • Islamic Finance
      • Islamic Personal Finance
    • Alternative Investments
  • Personal Finance
    • Cash Management
    • Grow Your Wealth
    • Protect Your Wealth
    • Distribute Your Wealth
    • Behavioural Finance
  • Enterprise
    • Startups
    • Entrepreneurs
    • SMEs
    • Leadership
    • Business Planning
    • Fintech
  • Property
    • First Time Home Buyers
    • Central
    • Northern
    • Southern
    • Sabah & Sarawak
    • Feature
    • Regional / Global
  • ESG
  • News & Events
  • What’s News Asia
No Result
View All Result
Smart Investor Malaysia
No Result
View All Result
Advertise with Smart Investor Advertise with Smart Investor Advertise with Smart Investor
Home HIDE FROM HOME

0xmd 與 SENAI CIMATEC 合作,正式啟動巴西業務

2 months ago
0
71
SHARES
140
VIEWS
Share on FacebookShare on Twitter
香港 – Media OutReach Newswire – 2025年5月12日 – 全球領先的醫療生成式人工智能初創企業 0xmd 宣布,已與巴西頂尖的科技與創新機構 SENAI CIMATEC 達成戰略合作協議。該合作標誌著 0xmd 正式在巴西啟動業務,進一步拓展其於拉丁美洲市場的影響力。

此次合作將使 0xmd 把多項尖端人工智能技術引進巴西,包括自動化臨床檢查分析、醫學影像剖析、以及具對話能力的診斷支援系統。通過此協議,0xmd 成為首家融合至 CIMATEC 創新生態系統的國際健康科技企業。

0xmd 目前已在美國與中國開展業務,致力於透過智能工具協助巴西醫療體系實現醫療服務普及化。這些工具可支援醫療專業人員進行診斷、治療規劃及個人化護理。0xmd 技術的一大特色,是其採用了專為醫療與健康領域訓練的大型語言模型,並結合自然語言介面(如臨床聊天機械人),促進醫護人員與決策支援系統之間的無縫互動。

0xmd 主席兼總架構師區兆倫(Allen Au)表示:「與 SENAI CIMATEC 建立合作關係,將使 0xmd 能夠根據巴西市場需求進行本地化,並在拉丁美州地區擴大我們的影響力。CIMATEC 在創新和科研領域的卓越聲譽,使其成為協助我們融入巴西醫療體系、成功落地技術的理想合作夥伴。」

根據協議,首階段將重點放在使 0xmd 技術符合巴西相關法規,同時與當地醫療系統結合。此外,此合作亦呼應了醫療產業對人工智能解決方案日益增加的需求,尤其是在影像診斷、全自動化醫學報告生成與個人化療法等應用領域。

此項夥伴關係強化了 0xmd 致力於推動全球醫療創新與擴展國際足跡的長遠承諾。
Hashtag: #0xmd

The issuer is solely responsible for the content of this announcement.

關於 0xmd

0xmd Inc.是生成式人工智能醫療保健解決方案平台的先驅,總部位於中國香港和美國,專注於為醫療應用設計的大型語言模型(LLM)和大型視覺語言模型(LvLM)。 0xmd能夠提供24/7傳統中醫和西醫結合的在線診斷支援、自動化臨床檢查分析、醫學影像診斷以及整體健康管理解決方案。公司致力於通過優化醫療保健體系來改變醫療行業格局,使醫療保健資源更加公平和普及。

https://www.0xmd.com

關於SENAI CIMATEC

SENAI CIMATEC 是巴西知名機構,擁有製造和技術集成方面的專業知識,旨在培育創新和創業生態系統。 它是一家私營非牟利法人實體,致力於建立國際合作並加速巴西的技術進步。

https://linktr.ee/senaicimatec_oficial

Previous Post

Tenchijin Inc. Announces Partnership with PWS in Malaysia for KnoWaterleak Distribution

Next Post

Siam Piwat Invites Modern Travelers to Discover the ‘ONESIAM Global Visitor Card,’ the Ultimate All-in-One Key to Premium Travel Experiences in Bangkok

Next Post

Siam Piwat Invites Modern Travelers to Discover the ‘ONESIAM Global Visitor Card,’ the Ultimate All-in-One Key to Premium Travel Experiences in Bangkok

Morningstar Awards 2024 Morningstar Awards 2024 Morningstar Awards 2024
  • Trending
  • Comments
  • Latest

Robo Advisor In Malaysia, 8 Robo Advisor Platforms To Choose From

17/08/2022
A calculator on financial chart, financial concept

Tax For The 6 Common Investments In Malaysia

19/09/2023

MRTT VS MRTA, What’s The Difference?

11/10/2023

How To Open A CDS And Share Trading Account?

02/05/2023

Digital Fundraising Platforms in Malaysia

Retirement Plans for the Self-Employed

SC Guidelines On Digital Assets

Retirement planning advise from the experts

Retirement Planning: Best Practices and Advice From Experts

Shopee Lancar MSME Co‑Lab Pertama di Malaysia Untuk Memperkukuh Sokongan kepada Usahawan Tempatan

12/07/2025

Shopee Launches First-Ever MSME Co-Lab in Malaysia to Strengthen Support for Local Entrepreneurs

12/07/2025

Wegovy® (semaglutide 2.4mg) by Novo Nordisk is now Available in Singapore for Weight Management

12/07/2025

第十三屆廣東核電站核安全諮詢委員會成立典禮暨第一次會議

12/07/2025

Shopee Lancar MSME Co‑Lab Pertama di Malaysia Untuk Memperkukuh Sokongan kepada Usahawan Tempatan

2 days ago

Shopee Launches First-Ever MSME Co-Lab in Malaysia to Strengthen Support for Local Entrepreneurs

2 days ago

Wegovy® (semaglutide 2.4mg) by Novo Nordisk is now Available in Singapore for Weight Management

2 days ago

第十三屆廣東核電站核安全諮詢委員會成立典禮暨第一次會議

2 days ago
The Smart Investor

© 2024 The SmartInvestor Malaysia | The contents on this website are for educational purposes only. You should always seek your own professional advice from the appropriate financial advisor or institution.

Category

  • About
  • Subscribe
  • Write For Us
  • Payment Policy
  • Shipping Policy
  • Privacy Policy
  • Contact Us

Sign up to read our newsletter

  • About
  • Contact Us
  • Home
  • Home (Bahasa Malayu)
  • Newsletter
  • Payment Policy
  • Privacy Policy
  • Shipping Policy
  • Subscribe
  • Write For Us

© 2024 The SmartInvestor Malaysia | The contents on this website are for educational purposes only. You should always seek your own professional advice from the appropriate financial advisor or institution.

No Result
View All Result
  • Start Here
    • Guides
    • How-Tos
    • Analysis
  • Investments
    • Asset Management
    • Stocks
    • Islamic Finance
      • Islamic Personal Finance
    • Alternative Investments
  • Personal Finance
    • Cash Management
    • Grow Your Wealth
    • Protect Your Wealth
    • Distribute Your Wealth
    • Behavioural Finance
  • Enterprise
    • Startups
    • Entrepreneurs
    • SMEs
    • Leadership
    • Business Planning
    • Fintech
  • Property
    • First Time Home Buyers
    • Central
    • Northern
    • Southern
    • Sabah & Sarawak
    • Feature
    • Regional / Global
  • ESG
  • News & Events
  • What’s News Asia

© 2024 The SmartInvestor Malaysia | The contents on this website are for educational purposes only. You should always seek your own professional advice from the appropriate financial advisor or institution.